Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02861014
Brief Title: A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

First Submitted : August 5, 2016
First Submitted that Met QC Criteria : August 5, 2016
First Posted : August 10, 2016 (Estimate)

Results First Submitted : October 13, 2020
Results First Submitted that Met QC Criteria : January 13, 2021
Results First Posted : February 3, 2021

Last Update Submitted that Met QC Criteria : March 24, 2021
Last Update Posted : March 26, 2021